This product eventually evolved to become the BD Vacutainer Blood Collection system. In 1947 Joseph Kleiner developed the Evacutainer - a device used to draw blood by vacuum through a needle into a test tube. Today, luer lock connectors are the standard for syringes in the U.S. It provided a simple and secure method of attaching and removing the needle to and from the syringe. One year later, BD introduced the BD Yale Luer-Lok Syringe, designed and patented by Fairleigh S. In 1924, BD manufactured its first syringe designed specifically for insulin injection. created specifically for the production of thermometers, hypodermic needles, and syringes. Two years later, BD incorporated in the State of New Jersey and built a manufacturing facility in East Rutherford, the first in the U.S. This very first acquisition and other early acquisitions significantly expanded the company’s manufacturing ability and product offering. In 1904, BD acquired the Philadelphia Surgical Company. In 1899 the company introduced its first logo which was meant to symbolize guaranteed superior quality of the products provided by BD. In 1898, BD acquired its first patent for a medical product. The same year the company made its first sale, a Luer-all-glass syringe that sold for $2.50. Dickinson, two American businessmen who met on a sales trip. “ “ Becton Dickinson Historical development 1897–1947īD was founded in 1897 by Maxwell W. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ. This segment product include fluorescence-activated cell sorters and analyzers monoclonal antibodies and kits for performing cell analysis reagent systems for life science research cell imaging systems diagnostic assays and cell culture media supplements for biopharmaceutical manufacturing. The BD Biosciences segment produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes.
This segment products include integrated systems for specimen collection safety-engineered blood collection products and systems automated blood culturing systems molecular testing systems for infectious diseases and women’s health microorganism identification and drug susceptibility systems liquid-based cytology systems for cervical cancer screening rapid diagnostic assays microbiology laboratory automation and plated media. The BD Diagnostics segment provides products for the safe collection and transport of diagnostics specimens, as well as instrument systems and reagents to detect a broad range of infectious diseases, healthcare-associated infections and cancers. This segment product include needles, syringes and intravenous catheters for medication delivery prefilled IV flush syringes syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Medical segment produces medical devices that are used in a wide range of healthcare settings. The company operates through three worldwide business segments: BD Medical, BD Diagnostics and BD Biosciences. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. 0 Views Becton, Dickinson & Company (BD) history, profile and corporate videoīecton, Dickinson & Co.
0 kommentar(er)
